Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. [PDF]
Valent P +25 more
europepmc +1 more source
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. [PDF]
Khoury JD +61 more
europepmc +1 more source
Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis. [PDF]
Dasilva-Freire N +13 more
europepmc +1 more source
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network. [PDF]
Zanotti R +8 more
europepmc +1 more source
Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches. [PDF]
Baran J +7 more
europepmc +1 more source
Mastocitosis sistémica y resonancia magnética [PDF]
García Erce, J. A. +2 more
openaire +3 more sources
Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. [PDF]
Alvarez-Twose I +9 more
europepmc +1 more source
Eficacia clínica de la Inmunoterapia Alérgeno Específica en el tratamiento de la Rinitis y el Asma Alérgicas [PDF]
Hernández Hernández, Mario Abel +1 more
core

